» Articles » PMID: 31555829

Risk Factors for Kaposi's Sarcoma-Associated Herpesvirus DNA in Blood and in Saliva in Rural Uganda

Overview
Journal Clin Infect Dis
Date 2019 Sep 27
PMID 31555829
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Detectable Kaposi's sarcoma-associated herpesvirus (KSHV) DNA in blood and increased antibody titres may indicate KSHV reactivation, while the transmission of KSHV occurs via viral shedding in saliva.

Methods: We investigated the risk factors for KSHV DNA detection by real-time polymerase chain reaction in blood and by viral shedding in saliva, in 878 people aged 3 to 89 years of both sexes in a rural Ugandan population cohort. Helminths were detected using microscopy and the presence of malaria parasitaemia was identified using rapid diagnostic tests. Regression modelling was used for a statistical analysis.

Results: The KSHV viral load in blood did not correlate with the viral load in saliva, suggesting separate immunological controls within each compartment. The proportions of individuals with a detectable virus in blood were 23% among children aged 3-5 years and 22% among those 6-12 years, thereafter reducing with increasing age. The proportions of individuals with a detectable virus in saliva increased from 30% in children aged 3-5 years to 45% in those aged 6-12 years, and decreased subsequently with increasing age. Overall, 29% of males shed in saliva, compared to 19% of females (P = .008).

Conclusions: Together, these data suggest that young males may be responsible for much of the onward transmission of KSHV. Individuals with a current malaria infection had higher levels of viral DNA in their blood (P = .031), compared to uninfected individuals. This suggests that malaria may lead to KSHV reactivation, thereby increasing the transmission and pathogenicity of the virus.

Citing Articles

Highly Heterogeneous Kaposi Sarcoma-Associated Herpesvirus Oral Shedding Kinetics Among People With and Without Kaposi Sarcoma and Human Immunodeficiency Virus Coinfection.

Krantz E, Mutyaba I, Nankoma J, Okuku F, Casper C, Orem J Open Forum Infect Dis. 2024; 11(10):ofae548.

PMID: 39371366 PMC: 11450676. DOI: 10.1093/ofid/ofae548.


Factors affecting Kaposi's sarcoma-associated herpesvirus transmission in rural Ugandan households, a longitudinal study.

Sabourin K, Marshall V, Eaton W, Kimono B, Mugisha J, Miley W Infect Agent Cancer. 2024; 19(1):49.

PMID: 39363326 PMC: 11451123. DOI: 10.1186/s13027-024-00610-6.


Factors affecting Kaposi's sarcoma-associated herpesvirus transmission in rural Ugandan households, a longitudinal study.

Sabourin K, Marshall V, Eaton W, Kimono B, Mugisha J, Miley W Res Sq. 2024; .

PMID: 39315255 PMC: 11419167. DOI: 10.21203/rs.3.rs-4855275/v1.


HIV-associated cancers and lymphoproliferative disorders caused by Kaposi sarcoma herpesvirus and Epstein-Barr virus.

Lurain K, Ramaswami R, Krug L, Whitby D, Ziegelbauer J, Wang H Clin Microbiol Rev. 2024; 37(3):e0002223.

PMID: 38899877 PMC: 11391709. DOI: 10.1128/cmr.00022-23.


Is human herpesvirus 8 infection more common in men than in women? an updated meta-analysis.

Gong H, Zhang S, Dou J, Chen J BMC Infect Dis. 2024; 24(1):454.

PMID: 38684967 PMC: 11059601. DOI: 10.1186/s12879-024-09346-5.


References
1.
Labo N, Miley W, Marshall V, Gillette W, Esposito D, Bess M . Heterogeneity and breadth of host antibody response to KSHV infection demonstrated by systematic analysis of the KSHV proteome. PLoS Pathog. 2014; 10(3):e1004046. PMC: 3968157. DOI: 10.1371/journal.ppat.1004046. View

2.
Engels E, Biggar R, Marshall V, Walters M, Gamache C, Whitby D . Detection and quantification of Kaposi's sarcoma-associated herpesvirus to predict AIDS-associated Kaposi's sarcoma. AIDS. 2003; 17(12):1847-51. DOI: 10.1097/00002030-200308150-00015. View

3.
Nalwoga A, Miley W, Labo N, Elliott A, Cose S, Whitby D . Age of Infection with Kaposi Sarcoma-Associated Herpesvirus and Subsequent Antibody Values Among Children in Uganda. Pediatr Infect Dis J. 2018; 37(8):e225-e228. PMC: 6010155. DOI: 10.1097/INF.0000000000001909. View

4.
Hulaniuk M, Torres O, Bartoli S, Fortuny L, Burgos Pratx L, Nunez F . Increased prevalence of human herpesvirus type 8 (HHV-8) genome among blood donors from North-Western Argentina. J Med Virol. 2016; 89(3):518-527. DOI: 10.1002/jmv.24656. View

5.
Nalwoga A, Cose S, Nash S, Miley W, Asiki G, Kusemererwa S . Relationship Between Anemia, Malaria Coinfection, and Kaposi Sarcoma-Associated Herpesvirus Seropositivity in a Population-Based Study in Rural Uganda. J Infect Dis. 2018; 218(7):1061-1065. PMC: 6107741. DOI: 10.1093/infdis/jiy274. View